QA: Balchem CORP in us_medicinal_products/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000009326_2013_Balchem_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000009326, Balchem CORP

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 30,234,000
2 remainder_Liabilities 9,299,000
3 AssetsCurrent 211,909,000
4 AssetsNoncurrent 538,000
5 PropertyPlantAndEquipmentNet 52,725,000
6 Goodwill 47,373,000
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 247,194,000
9 ResearchAndDevelopmentExpense 3,422,000
10 remainder_Expenses 19,849,000
11 remainder_Revenues 310,393,000
12 remainder_NetIncome 77,000
13 remainder_ComprehensiveNetIncome 179,000
  yvar yval
0 Liabilities 39,533,000
1 Assets 312,545,000
2 Expenses 270,465,000
3 Revenues 310,393,000
4 StockholdersEquity 273,012,000
5 NetIncome 40,005,000
6 ComprehensiveNetIncome 40,094,500
7 BaseVar 466,596,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.35
9 EconomicCapitalRatio 2.60

Edgar->Model Mapping

Feature Distribution